PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Hypurin Bovine Neutral 100units/ml inj 3ml cartridges
0601011N0BCAGAY
Insulin soluble (CP Pharm) Soluble insulin (Neutral insulin) Endocrine System No data available
Hypurin Bovine Protamine Zinc 100units/ml inj 10ml vials
0601012U0BBAAAA
Insulin Hypurin Bovine Protamine Zinc Protamine zinc insulin Endocrine System No data available
Hypurin Porcine 30/70 Mix 100units/ml inj 1.5ml cartridges
0601012D0BEAHBD
Insulin biphasic isophane (CP Pharm) Biphasic isophane insulin Endocrine System No data available
Hypurin Porcine Isophane 100units/ml inj 1.5ml cartridges
0601012S0BCAFAP
Insulin isophane (CP Pharm) Isophane insulin Endocrine System No data available
Hypurin Porcine Neutral 100units/ml inj 1.5ml cartridges
0601011N0BCAFAU
Insulin soluble (CP Pharm) Soluble insulin (Neutral insulin) Endocrine System No data available
Ibandronic acid 2mg/2ml solution for infusion ampoules
0606020W0AAAAAA
Ibandronic acid Ibandronic acid Endocrine System No data available
Ibandronic acid 2mg/2ml solution for infusion vials
0606020W0AAAFAF
Ibandronic acid Ibandronic acid Endocrine System No data available
Ibandronic acid 6mg/6ml solution for infusion vials
0606020W0AAACAC
Ibandronic acid Ibandronic acid Endocrine System No data available
iHealth testing strips
0601060D0DYAAA0
iHealth (Reagent) Glucose blood testing reagents Endocrine System No data available
IME-DC testing strips
0601060D0CWAAA0
IME-DC (Reagent) Glucose blood testing reagents Endocrine System No data available
Increlex 40mg/4ml solution for injection vials
0607040A0BBAAAA
Increlex Mecasermin Endocrine System No data available
Ins isoph biphas hum 50/50 100u/ml inj 3ml pf dispos dev
0601012D0AABXBX
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulatard FlexPen 100units/ml suspension for injection
0601012S0BDANAI
Insulin isophane (Novo-Nordisk) Isophane insulin Endocrine System No data available
Insulatard NovoLet 100units/ml suspension for injection
0601012S0BDAIAI
Insulin isophane (Novo-Nordisk) Isophane insulin Endocrine System No data available
Insulin human 100units/ml inj 3.15ml cartridges
0601011R0AAACAC
Insulin human Insulin human Endocrine System No data available
Insulin human 100units/ml solution for injection 10ml vials
0601011R0AAADAD
Insulin human Insulin human Endocrine System No data available
Insulin human 1mg inhalation powder blisters
0601011Q0AAAAAA
Insulin human inhaled Insulin human inhaled Endocrine System No data available
Insulin human 3mg inhalation powder blisters
0601011Q0AAABAB
Insulin human inhaled Insulin human inhaled Endocrine System No data available
Insulin human 500units/ml solution for injection 20ml vials
0601011R0AAABAB
Insulin human Insulin human Endocrine System No data available
Insulin isoph biphas hum 10/90 100u/ml inj 3ml pf dispos dev
0601012D0AABQBQ
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulin isoph biphas hum 15/85 100u/ml inj 3ml pf dispos dev
0601012D0AABVBV
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulin isoph biphas hum 20/80 100u/ml inj 3ml pf dispos dev
0601012D0AAA3A3
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulin isoph biphas hum 40/60 100u/ml inj 3ml pf dispos dev
0601012D0AABHBH
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulin isophane biphas hum 15/85 100units/ml inj 5ml vials
0601012D0AABRBR
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available
Insulin isophane biphas hum 25/75 100units/ml inj 5ml vials
0601012D0AABMBM
Biphasic isophane insulin Biphasic isophane insulin Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.